Powered by
All the data and insights you need on DaVita Inc in one report.
$295
Buy Report View Sample
- Save hours of research time and resources with
our up-to-date DaVita Inc Strategy Report - Understand DaVita Inc position in the market,
performance and strategic initiatives. - Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
- Overview
- Segment Analysis
- Financials
- Executives
- SWOT Analysis
- Locations
- Competitors
- Deals
- Filing Analytics
- Patents
- Theme Exposure
- Media
- Premium Data
- Clinical Trials
- Investigators
- Catalyst Calendar
- Lead Sheet
- Insights
DaVita Inc (DaVita) provides dialysis services and integrated health care management services. The company caters to patients with chronic kidney failure and end-stage renal disease (ESRD). It offers various ancillary services, including therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services. The company operates through a network of outpatient dialysis centers in hospitals and related laboratory services. It has an operational presence in Arizona, California, Nevada, Florida, New Mexico, and Colorado. DaVita is headquartered in Denver, Colorado, the US.
Gain a 360-degree view of DaVita Inc and make more informed decisions for your business Gain a 360-degree view of DaVita Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 2000 16th St, Denver, Colorado, 80202-5158
Website www.davita.com
Telephone 1 310 5362668
No of Employees 70,000
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange DVA (NYSE)
Revenue (2022) $12.1B 4.6% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ 23.4% (2022 vs 2021)
Market Cap* $12.5B
Net Profit Margin (2022) XYZ 18.0% (2022 vs 2021)
* As of and is in US$
View DaVita Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more
DaVita Inc premium industry data and analytics
120+
Clinical Trials
Determine DaVita Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
50+
Investigators
Review investigator profiles and find information on trial contacts across DaVita Inc, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.
40+
Catalyst Calendar
Proactively evaluate DaVita Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
20+
Lead Sheet
Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for DaVita Inc’s relevant decision makers and contact details.
8
Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
1
IT Client Prospector provides intelligence on DaVita Inc’s likely spend across technology areas enabling you to understand the digital strategy.
Products and Services
Services | Brands |
---|---|
Outpatient Dialysis Services | Davita |
Hospital Inpatient Dialysis Services | |
Insurance and Financial Management | |
XYZ | |
XYZ | |
XYZ |
Understand DaVita Inc portfolio and identify potential areas for collaboration Understand DaVita Inc portfolio and identify potential areas for collaboration Find out more
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Contracts/Agreements | In June, the company expanded its agreement with Nuwellis to use Aquadex ultrafiltration therapy for adult patients suffering from congestive heart failure. |
2024 | Contracts/Agreements | In March, the company entered into a collaboration with The American Diabetes Association (ADA) to focus on addressing chronic diseases. |
2024 | Contracts/Agreements | In March, the company entered into an agreement to acquire the dialysis clinic networks from Fresenius Medical Care AG. |
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Competitor Comparison
Key Parameters | DaVita Inc | Fresenius Medical Care AG & Co KGaA | Baxter International Inc | Dialysis Corp of America | Northwest Kidney Centers |
---|---|---|---|---|---|
Headquarters | United States of America | Germany | United States of America | United States of America | United States of America |
City | Denver | Bad Homburg Vor Der Hohe | Deerfield | Linthicum | Seattle |
State/Province | Colorado | Hessen | Illinois | Maryland | Washington |
No. of Employees | 70,000 | 117,128 | 60,000 | - | - |
Entity Type | Public | Public | Public | Private | Institution |
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Key Financial Charts
Sales Growth
![DaVita Inc Company Profile - DaVita Inc Overview (3) DaVita Inc Company Profile - DaVita Inc Overview (3)](https://i0.wp.com/assets.globaldata.com/gdcom/assets/img/ajax-loadernew.gif)
Net Income Growth
![DaVita Inc Company Profile - DaVita Inc Overview (4) DaVita Inc Company Profile - DaVita Inc Overview (4)](https://i0.wp.com/assets.globaldata.com/gdcom/assets/img/ajax-loadernew.gif)
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Javier J. Rodriguez | Chief Executive Officer; Director | Executive Board | 2019 | 53 |
Pamela M. Arway | Chair | Executive Board | 2020 | 70 |
Joel Ackerman | Chief Financial Officer; Treasurer | Senior Management | 2017 | 58 |
Christopher M. Berry | Chief Accounting Officer | Senior Management | 2023 | - |
Madhu Narasimhan | Chief Information Officer | Senior Management | 2024 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Gain insight into DaVita Inc key executives to enhance your sales strategy Gain insight into DaVita Inc key executives to enhance your sales strategy Find out more
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer